Use of PD-L1 Low Expression Status to Select Subjects for Cancer Immunotherapy
The disclosure relates to methods for treating cancer or selecting subjects for cancer treatment using low PD-L1 expression as a patient biomarker prior to treatment.
Saved in:
| Main Authors | , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
13.02.2025
|
| Subjects | |
| Online Access | Get full text |
Cover
| Abstract | The disclosure relates to methods for treating cancer or selecting subjects for cancer treatment using low PD-L1 expression as a patient biomarker prior to treatment. |
|---|---|
| AbstractList | The disclosure relates to methods for treating cancer or selecting subjects for cancer treatment using low PD-L1 expression as a patient biomarker prior to treatment. |
| Author | FISHER, Terry ZAUDERER, Maurice EVANS, Elizabeth |
| Author_xml | – fullname: EVANS, Elizabeth – fullname: ZAUDERER, Maurice – fullname: FISHER, Terry |
| BookMark | eNqNyr0KwjAQAOAMOvj3DgfOhTYSOkutKBQRYucSwxWVNhdyCerb6-ADOH3LNxcTRw5n4tQyAvVw3mVNAQ09oX75gMx3cqCjiYkhEmgc0EbQ6fr4ytBTgMo4iwGO45gcxRsG499LMe3NwLj6uRDrfX2pDhl66pC9segwdq2WuVS5kqUqt8Xmv_UBUSY3_g |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences Physics |
| ExternalDocumentID | US2025052757A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_US2025052757A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Mar 28 04:49:15 EDT 2025 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_US2025052757A13 |
| Notes | Application Number: US202418799733 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20250213&DB=EPODOC&CC=US&NR=2025052757A1 |
| ParticipantIDs | epo_espacenet_US2025052757A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20250213 |
| PublicationDateYYYYMMDD | 2025-02-13 |
| PublicationDate_xml | – month: 02 year: 2025 text: 20250213 day: 13 |
| PublicationDecade | 2020 |
| PublicationYear | 2025 |
| RelatedCompanies | Vaccinex, Inc MSD International GmbH |
| RelatedCompanies_xml | – name: Vaccinex, Inc – name: MSD International GmbH |
| Score | 3.5021002 |
| Snippet | The disclosure relates to methods for treating cancer or selecting subjects for cancer treatment using low PD-L1 expression as a patient biomarker prior to... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING |
| Title | Use of PD-L1 Low Expression Status to Select Subjects for Cancer Immunotherapy |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20250213&DB=EPODOC&locale=&CC=US&NR=2025052757A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8Q_HzTqUFF00Szt0W7bgMeiJFtBA0MIszwRljXJSZmI2wE_e-91qE88dhrcmmvubtfr3dXgHtmcUtELRm556Zh8dgxmnHUNOYJj23BKKcq3jEInF5ovU7taQU-N7Uwqk_oWjVHRI3iqO-FsteL_yCWp3Ir84foA0nZU3fS9vTydoz-3KRM9zptfzT0hq7uuu1wrAdvv3O22bAbz3hX2jNt5kg19t87si5lse1UuiewP0J-aXEKFZFqcORu_l7T4HBQPnlrcKByNHmOxFIP8zMIwlyQLCEjz-hT0s_WxP8qM1pTIvHjKidFRsbqkxuCxkFGW3KCAJW48piX5EXWhZTVV9_ncNf1J27PwCXO_iQyC8fb-2EXUE2zVNSAILrgCbNR5C1qJRzx1WNMxbyZ4JkkCKYuob6L09Xu6Ws4lkOZtExZHarFciVu0CcX0a0S5Q-ZpY9O |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8JADG8IfuCbogYV9RLN3hY9tsF4IEY2lqFjEGGGN8Jut8TEbISNoP-9vXMoT7xek-auTdtfe-0dwL2mM52HbVG5Zw1VZ1FTNaPQVOcxiwyuUUZlvWPgN91Af5ka0xJ8bmZh5Duha_k4IloUQ3vPpb9e_BexbNlbmT2EH7iUPjmTjq0U2THG8wbVFLvb6Y2G9tBSLKsTjBX_7ZdmNFpG6xlzpT10AaZM2967Yi5lsR1UnGPYHyG_JD-BEk-qULE2f69V4XBQXHlX4UD2aLIMFws7zE7BDzJO0piMbNWjxEvXpPdVdLQmRODHVUbylIzlJzcEnYOotmQEASqxhJqXpC_mQorpq-8zuHN6E8tVcYuzP4nMgvH2ebRzKCdpwmtAEF2wWDNQ5G2qxwzx1WNE-dyMUScxgqkLqO_idLmbfAsVdzLwZl7ff72CI0ESDcxUq0M5X674NcbnPLyRYv0BhGWSRQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Use+of+PD-L1+Low+Expression+Status+to+Select+Subjects+for+Cancer+Immunotherapy&rft.inventor=EVANS%2C+Elizabeth&rft.inventor=ZAUDERER%2C+Maurice&rft.inventor=FISHER%2C+Terry&rft.date=2025-02-13&rft.externalDBID=A1&rft.externalDocID=US2025052757A1 |